Citation Impact
Citing Papers
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
2006
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
GASTROESOPHAGEAL REFLUX DISEASE IN PATIENTS WITH COLUMNAR-LINED ESOPHAGUS
1997
Functional Gastroduodenal Disorders
2006 Standout
Physicochemical and Physiological Mechanisms for the Effects of Food on Drug Absorption: The Role of Lipids and pH
1997
AGA technical review: Evaluation of dyspepsia
1998
The β-Thalassemias
1999 Standout
Validity and Clinical Utility of the Aspartate Aminotransferase–Alanine Aminotransferase Ratio in Assessing Disease Severity and Prognosis in Patients With Hepatitis C Virus–Related Chronic Liver Disease
2003
No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis
2018
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
2005 Standout
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Dyspepsia and Health Care Seeking in a Community (How Important Are Psychological Factors?)
1998
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis
2009
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
2004 Standout
Hepatitis B virus infection
2009 Standout
Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging Assessment
2006
Herbal hepatotoxicity: An expanding but poorly defined problem
2000
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
2005 Standout
MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study
2002
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Management of Hepatocellular Carcinoma *
2005 Standout
Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration
1996
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Herbal Hepatotoxicity
2007
Predominant Symptoms Identify Different Subgroups in Functional Dyspepsia
1999
Quantum imaging with undetected photons
2014 StandoutNatureNobel
Decreased serum aminotransferase activity in patients with chronic renal failure: Impact on the detection of viral hepatitis
2001
Regulation of cancer cell metabolism
2011 Standout
Antimony electrodes
1990
Chronic hepatitis B
2007 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis
1997
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
1999 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Famotidine for the Prevention of Gastric and Duodenal Ulcers Caused by Nonsteroidal Antiinflammatory Drugs
1996
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
2014
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Role of Glutamine Depletion in Directing Tissue-specific Nutrient Stress Responses to L-Asparaginase
2006
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Non‐alcoholic fatty liver disease – a common and benign finding in octogenarian patients
2004
Hepatitis C Virus‐Specific Cytolytic T Lymphocyte and T Helper Cell Responses in Seronegative Persons
1997 StandoutNobel
A meta-analysis of antimycobacterial therapy for Crohn's disease
2000
The utility of radiological imaging in nonalcoholic fatty liver disease
2002 Standout
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Noninvasive Measures of Liver Fibrosis
2006
The Risk of Transfusion-Transmitted Viral Infections
1996 Standout
Natural history of liver fibrosis progression in patients with chronic hepatitis C
1997 Standout
Peptic ulcer disease
2009
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers
1999
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
Hepatitis C: Natural History of a Unique Infection
1995
Predicting Endoscopic Diagnosis in the Dyspeptic Patient: The Value of Predictive Score Models
1997
A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta
1988 StandoutNobel
Hepatocellular Carcinoma
2019 Standout
Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?
2010
Generation of an MHC Class II-Restricted T Cell Epitope by Extracellular Processing of Hepatitis δ Antigen
1998 StandoutNobel
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
The distribution and localization of the monoclonal antibody-defined antigen 19-9 (CA19-9) in chronic pancreatitis and pancreatic carcinoma
1986
SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER
1986
Comparison of Five In Vitro Digestion Models To Study the Bioaccessibility of Soil Contaminants
2002 Standout
INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B
1982
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Structure, sequence and expression of the hepatitis delta (δ) viral genome
1986 StandoutNatureNobel
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles
1997 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Quality Indicators for Colonoscopy
2006
Potential and Challenges for Mid-Infrared Sensors in Breath Diagnostics
2009
The Delta Agent
1983
Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland.
2000
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection
2001
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Linkage of gut microbiome with cognition in hepatic encephalopathy
2011
Test Characteristics of α-Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis C
2003
Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States
2000
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Carrier-Based Ion-Selective Electrodes and Bulk Optodes. 2. Ionophores for Potentiometric and Optical Sensors
1998 Standout
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Nonalcoholic Fatty Liver Disease
2015 Standout
Works of G Celle being referenced
The 13 C urea breath test in the diagnosis of Helicobacter pylori infection
1999
24-hour study of intragastric acidity in duodenal ulcer patients and normal subjects using continuous intraluminal pH-metry
1988
Antimycobacterial chemotherapy in inflammatory bowel disease
1989
Variability in individual response to various doses of omeprazole
1994
Lymphoblastoid interferon therapy in chronic hepatitis C: biochemical, virological and histological evaluation of two different doses
1995
Interferon therapy in chronic hepatitis C
1993
Evaluation of antisecretory activity of misoprostol in duodenal ulcer patients using long-term intragastric pH monitoring
1988
Chronic hepatitis induced by Jin Bu Huan
1998
Is hepatic ultrasonography a valid alternative tool to liver biopsy? report on 507 cases studied with both techniques
1988
Chronic liver disease related to hepatitis C virus
1999
Time pattern of gastric acidity in Barrett's esophagus
1996
Progressive Liver Functional Impairment Is Associated with an Increase in AST/ALT Ratio
1999
HCV-RNA levels play an important role independently of genotype in predicting response to interferon therapy
1997
Patterns of dyspepsia in patients with no clinical evidence of organic diseases
1990
Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: An early predictor marker of response?
1995
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients
1997
Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis
1996
Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
1998
Open Access Endoscopy
1993
Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients.
1993
Percutaneous or laparoscopic needle biopsy in the evaluation of chronic liver disease?
1984
Evaluation of a New Tumor-Associated Antigen in Pancreatic Cancer
1984
Continuous 24-Hour Intragastric pH Monitoring in the Evaluation of the Effect of a Nightly Dose of Famotidine, Ranitidine and Placebo on Gastric Acidity of Patients with Duodenal Ulcer
1987
Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease.
1997
Toxic and immunodepressive effects of L-asparaginase from E. coli and from Erwinia carotovora following chronic administration in rats.
1977
Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients
1993
Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?
2001
Interplay of Cell and Serum Immunologic Markers in Chronic Persistent or Active Hepatitis B
1981